Cytodyn OTC Stock Odds of Future OTC Stock Price Finishing Over 0.35

CYDY
 Stock
  

USD 0.35  0.01  2.78%   

Cytodyn's future price is the expected price of Cytodyn instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cytodyn performance during a given time horizon utilizing its historical volatility.
  
Continue to Cytodyn Backtesting, Cytodyn Valuation, Cytodyn Correlation, Cytodyn Hype Analysis, Cytodyn Volatility, Cytodyn History as well as Cytodyn Performance. Please specify Cytodyn time horizon, a valid symbol (red box) and a target price (blue box) you would like Cytodyn odds to be computed.

Cytodyn Target Price Odds to finish over 0.35

The tendency of Cytodyn OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.35 90 days 0.35 
about 85.29
Based on a normal probability distribution, the odds of Cytodyn to move above the current price in 90 days from now is about 85.29 (This Cytodyn probability density function shows the probability of Cytodyn OTC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Cytodyn has a beta of 0.73 suggesting as returns on the market go up, Cytodyn average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cytodyn will be expected to be much smaller as well. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Cytodyn is significantly underperforming NYSE Composite.
   Cytodyn Price Density   
       Price  

Predictive Modules for Cytodyn

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cytodyn. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cytodyn's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cytodyn in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.020.357.00
Details
Intrinsic
Valuation
LowReal ValueHigh
0.020.357.00
Details
Naive
Forecast
LowNext ValueHigh
0.0071850.367.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.320.360.40
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytodyn. Your research has to be compared to or analyzed against Cytodyn's peers to derive any actionable benefits. When done correctly, Cytodyn's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cytodyn.

Cytodyn Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cytodyn is not an exception. The market had few large corrections towards the Cytodyn's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cytodyn, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cytodyn within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.36
β
Beta against NYSE Composite0.73
σ
Overall volatility
0.09
Ir
Information ratio -0.06

Cytodyn Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cytodyn for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cytodyn can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cytodyn generated a negative expected return over the last 90 days
Cytodyn has high historical volatility and very poor performance
Cytodyn has some characteristics of a very speculative penny stock
The company currently holds 37.35 M in liabilities. Cytodyn has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cytodyn until it has trouble settling it off, either with new capital or with free cash flow. So, Cytodyn's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cytodyn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cytodyn to invest in growth at high rates of return. When we think about Cytodyn's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 266 K. Net Loss for the year was (210.82 M) with loss before overhead, payroll, taxes, and interest of (73.28 M).
Cytodyn currently holds about 4.68 M in cash with (77.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Cytodyn Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cytodyn OTC Stock often depends not only on the future outlook of the current and potential Cytodyn's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytodyn's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding719585000.00
Cash And Short Term Investments4231000.00

Cytodyn Technical Analysis

Cytodyn's future price can be derived by breaking down and analyzing its technical indicators over time. Cytodyn OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cytodyn. In general, you should focus on analyzing Cytodyn OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Cytodyn Predictive Forecast Models

Cytodyn time-series forecasting models is one of many Cytodyn's otc stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cytodyn's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Cytodyn

Checking the ongoing alerts about Cytodyn for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cytodyn help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cytodyn generated a negative expected return over the last 90 days
Cytodyn has high historical volatility and very poor performance
Cytodyn has some characteristics of a very speculative penny stock
The company currently holds 37.35 M in liabilities. Cytodyn has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cytodyn until it has trouble settling it off, either with new capital or with free cash flow. So, Cytodyn's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cytodyn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cytodyn to invest in growth at high rates of return. When we think about Cytodyn's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 266 K. Net Loss for the year was (210.82 M) with loss before overhead, payroll, taxes, and interest of (73.28 M).
Cytodyn currently holds about 4.68 M in cash with (77.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Continue to Cytodyn Backtesting, Cytodyn Valuation, Cytodyn Correlation, Cytodyn Hype Analysis, Cytodyn Volatility, Cytodyn History as well as Cytodyn Performance. Note that the Cytodyn information on this page should be used as a complementary analysis to other Cytodyn's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Cytodyn OTC Stock analysis

When running Cytodyn price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Please note, there is a significant difference between Cytodyn's value and its price as these two are different measures arrived at by different means. Investors typically determine Cytodyn value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytodyn's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.